The interest in GLP-1 medications for Hashimoto's patients often stems from their metabolic effects rather than direct thyroid benefits
Struggling with nausea on Wegovy, Zepbound, or another GLP-1
GLP-1 medications reduce appetite, but rapid or aggressive calorie deficits increase the risk of muscle loss
Retatrutide and newer agents Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon receptors, is still in clinical development but early data suggest similar gastrointestinal side effect profiles
Side effects were more common in the oral semaglutide group (16.7%) than in the injection group (4.9%)
Poor sleep on Mounjaro can also be linked to eating too late, dehydration, or discomfort when lying down after a meal